<?xml version="1.0" encoding="UTF-8"?><doi_batch version="4.3.7" xmlns="http://www.crossref.org/schema/4.3.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd">
		<head>
		<doi_batch_id>cirpublications.com-hrUf-1790880678-t715039840</doi_batch_id>
		<timestamp>1790880678</timestamp>
		<depositor>
			<depositor_name>Clinical Intelligence Research Press</depositor_name>
			<email_address>info@cirpublications.com</email_address>
		</depositor>
		<registrant>Clinical Intelligence Research Press</registrant>
	</head>
	<body>
		<journal>
			<journal_metadata>
				<full_title>Journal of Artificial Intelligence for Healthcare Systems</full_title>
				<abbrev_title>J. Artif. Intell. Healthc. Syst.</abbrev_title>
				<issn>3149-8981</issn>
			</journal_metadata>
			<journal_issue>
				<publication_date>
					<year>2026</year>
				</publication_date>
				<journal_volume>
					<volume>5</volume>
				</journal_volume>
				<issue>1</issue>
			</journal_issue>
			<journal_article publication_type="full_text">
				<titles>
					<title>Deep Learning for Oncology Drug Discovery: A Systematic Review of Target Identification, Compound Screening, and Clinical Trial Optimization</title>
				</titles>
								<contributors>
          					<person_name sequence="first" contributor_role="author">
            <given_name>Sophie</given_name>
            <surname>Laurent</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Pierre</given_name>
            <surname>Dubois</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Marc</given_name>
            <surname>Lefevre</surname>
					</person_name>
          					<person_name sequence="additional" contributor_role="author">
            <given_name>Claire</given_name>
            <surname>Moreau</surname>
					</person_name>
          				</contributors>
								<publication_date>
					<year>2026</year>
				</publication_date>
				<doi_data>
					<doi>10.68159/t715039840</doi>
					<resource>https://cirpublications.com/pub/journal/1/article/t715039840</resource>
				</doi_data>
				<citation_list>
          					<citation key="rk-10.68159/t715039840-5ac5282f-56a0-4918-bccd-5a71153a310e">
					  <unstructured_citation>You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S, et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther. 2022;7(1):156.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-1f9e1f74-c7ef-4568-ac66-a647775e060c">
					  <unstructured_citation>Pun FW, Ozerov IV, Zhavoronkov A. AI-powered therapeutic target discovery. Trends Pharmacol Sci. 2023;44(9):561-72.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-03d71649-058f-4351-8ec7-009fe490bf57">
					  <unstructured_citation>Preuer K, Lewis RP, Hochreiter S, Bender A, Bulusu KC, Klambauer G. DeepSynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics. 2018;34(9):1538-46.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-4f02bc46-c34e-4740-bfd7-9c6b2e6d07de">
					  <unstructured_citation>Öztürk H, Özgür A, Ozkirimli E. DeepDTA: deep drug–target binding affinity prediction. Bioinformatics. 2018;34(17):i821-i829.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-35cea874-a518-4189-a987-bef59f5b9594">
					  <unstructured_citation>Zhavoronkov A, Ivanenkov YA, Aliper A, Veselov MS, Aladinskiy VA, Aladinskaya AV, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. 2019;37(9):1038-40.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-26bc016a-0e00-46e6-b938-22cd6b83a71e">
					  <unstructured_citation>Méndez-Lucio O, Baillif B, Clevert DA, Rouquié D, Wichard J. De novo generation of hit-like molecules from gene expression signatures using artificial intelligence. Nat Commun. 2020;11(1):10.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-2f8cf9a2-b9c0-4d9d-a950-57f88ab6d26b">
					  <unstructured_citation>Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, et al. A deep learning approach to antibiotic discovery. Cell. 2020;180(4):688-702.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-ebe78f27-1615-40d3-b821-b48490a525fa">
					  <unstructured_citation>Liu R, Rizzo S, Whipple S, Pal N, Pineda AL, Lu M, et al. Evaluating eligibility criteria of oncology trials using real-world data and AI. Nature. 2021;592(7855):629-33.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-1967d6a1-8aa0-4be1-a52b-649a695b7b65">
					  <unstructured_citation>Xiong Z, Wang D, Liu X, Zhong F, Wan X, Li X, et al. Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism. J Med Chem. 2019;63(16):8749-60.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-6f1491f4-8cec-4f5b-82d5-b63084b51b19">
					  <unstructured_citation>Sharifi-Noghabi H, Zolotareva O, Collins CC, Ester M. MOLI: multi-omics late integration with deep neural networks for drug response prediction. Bioinformatics. 2019;35(14):i501-i509.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-ec3bbf55-dada-4993-9b30-aa58dc74fc0e">
					  <unstructured_citation>Chiu YC, Zheng S, Wang LJ, Iskra BS, Rao MK, Houghton PJ, et al. Predicting and characterizing a cancer dependency map of tumors with deep learning. Sci Adv. 2021;7(34):eabh1275.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-9a2d99b0-e9b8-427a-8522-ac236ab3f308">
					  <unstructured_citation>Pan X, Lin X, Cao D, Zeng X, Yu PS, He L, et al. Deep learning for drug repurposing: methods, databases, and applications. Wiley Interdiscip Rev Comput Mol Sci. 2022;12(4):e1597.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-6dec3a97-0a43-4082-9788-688c1f226461">
					  <unstructured_citation>Yang K, Swanson K, Jin W, Coley C, Eiden P, Gao H, et al. Analyzing learned molecular representations for property prediction. J Chem Inf Model. 2019;59(8):3370-88.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-4da2b8a2-df17-4cea-a579-97dd35c24a49">
					  <unstructured_citation>Huang K, Fu T, Glass LM, Zitnik M, Xiao C, Sun J. DeepPurpose: a deep learning library for drug–target interaction prediction. Bioinformatics. 2020;36(22-23):5545-7.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-31d6ef14-74be-44cc-879f-5635dbff9aa6">
					  <unstructured_citation>Nguyen T, Le H, Quinn TP, Nguyen T, Le TD, Venkatesh S. GraphDTA: predicting drug–target binding affinity with graph neural networks. Bioinformatics. 2021;37(8):1140-7.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-785f2588-7895-4166-a1a3-74171b667e54">
					  <unstructured_citation>Liu R, Wei L, Zhang P. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nat Mach Intell. 2021;3(1):68-75.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-95821708-a93b-4f9f-980f-08a60380f05d">
					  <unstructured_citation>Issa NT, Stathias V, Schürer S, Dakshanamurthy S. Machine and deep learning approaches for cancer drug repurposing. Semin Cancer Biol. 2021;68:132-42.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-7f5074aa-d4b0-443d-82d6-6c64bdc45e14">
					  <unstructured_citation>Cadow J, Born J, Manica M, Oskooei A, Rodríguez Martínez M. PaccMann: a web service for interpretable anticancer compound sensitivity prediction. Nucleic Acids Res. 2020;48(W1):W502-W508.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-0882d210-07a1-4568-8c79-0689b211ef95">
					  <unstructured_citation>Lin CH, Lichtarge O. Using interpretable deep learning to model cancer dependencies. Bioinformatics. 2021;37(17):2675-81.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-205aeec7-c541-4356-958d-64545e9a4fa8">
					  <unstructured_citation>Salem M, Khormali A, Arshadi AK, Webb J, Yuan JS. Transcreen: transfer learning on graph-based anti-cancer virtual screening model. Big Data Cogn Comput. 2020;4(3):16.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-158d5e48-b164-4322-b70c-e1dee48d6f3f">
					  <unstructured_citation>Song Q, Li M, Li Q, Lu X, Song K, Zhang Z, et al. DeepAlloDriver: a deep learning-based strategy to predict cancer driver mutations. Nucleic Acids Res. 2023;51(W1):W129-W133.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-21685db5-db0b-4717-a381-55aed4d34b71">
					  <unstructured_citation>Schwaller P, Laino T, Gaudin T, Bolgar P, Hunter CA, Bekas C, et al. Molecular transformer: a model for uncertainty-calibrated chemical reaction prediction. ACS Cent Sci. 2019;5(9):1572-83.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-0475f797-71b1-4387-a27f-ecdc3a6998cb">
					  <unstructured_citation>Nguyen T, Nguyen GT, Nguyen T, Le DH. Graph convolutional networks for drug response prediction. IEEE/ACM Trans Comput Biol Bioinform. 2021;19(1):146-54.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-62f256e7-1072-4c74-b989-a08874850023">
					  <unstructured_citation>Oloulade BM, Gao J, Chen J, Al-Sabri R, Wu Z. Cancer drug response prediction with surrogate modeling-based graph neural architecture search. Bioinformatics. 2023;39(8):btad478.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-8607afa7-691a-4859-ad43-c15942d2d53c">
					  <unstructured_citation>Born J, Manica M, Oskooei A, Cadow J, Markert G, Martínez MR. PaccMannRL: de novo generation of hit-like anticancer molecules from transcriptomic data via reinforcement learning. iScience. 2021;24(4):102269.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-cda7acdf-55c2-4161-8404-332c719ca684">
					  <unstructured_citation>Huang K, Xiao C, Glass LM, Sun J. MolTrans: molecular interaction transformer for drug–target interaction prediction. Bioinformatics. 2021;37(6):830-6.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-194805c9-335d-46ca-a509-d2876d0f194a">
					  <unstructured_citation>Olawade DB, Fidelis SC, Marinze S, Egbon E, Osunmakinde A, Osborne A. Artificial intelligence in clinical trials: a comprehensive review of opportunities, challenges, and future directions. Int J Med Inform. 2025;105:106141.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-82e40b69-4855-4c87-9ebb-0bac27c48023">
					  <unstructured_citation>Vishwakarma S, Hernandez-Hernandez S, Ballester PJ. Graph neural networks are promising for phenotypic virtual screening on cancer cell lines. Biol Methods Protoc. 2024;9(1):bpae065.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-e61b713e-1215-4269-8364-515404993a49">
					  <unstructured_citation>Shayakhmetov R, Kuznetsov M, Zhebrak A, Kadurin A, Nikolenko S, Aliper A, et al. Molecular generation for desired transcriptome changes with adversarial autoencoders. Front Pharmacol. 2020;11:269.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-ed657ad2-fba5-47bf-8312-4dd6d95fc40b">
					  <unstructured_citation>Zeng Z, Mao C, Vo A, Li X, Nugent JO, Khan SA, et al. Deep learning for cancer type classification and driver gene identification. BMC Bioinformatics. 2021;22(Suppl 4):491.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-64c61bdb-c10f-4425-ba01-a1691898b09c">
					  <unstructured_citation>Lu X, Yang C, Liang L, Hu G, Zhong Z, Jiang Z. Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review. J Am Med Inform Assoc. 2024;31(11):2749-59.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-f0795482-40a0-493b-8d04-4b147b03d0b8">
					  <unstructured_citation>Hooshmand SA, Zarei Ghobadi M, Hooshmand SE, Azimzadeh Jamalkandi S, Alavi SM, Masoudi-Nejad A. A multimodal deep learning-based drug repurposing approach for treatment of COVID-19. Mol Divers. 2021;25(3):1717-30.</unstructured_citation>
											</citation>
          					<citation key="rk-10.68159/t715039840-8ec6b3b0-18a8-4588-bb9e-0b3cac7dfea1">
					  <unstructured_citation>Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5-W14.</unstructured_citation>
											</citation>
          				</citation_list>
			</journal_article>
		</journal>
	</body>
</doi_batch>
